Across TCGA pan-cancer cohorts, UBE2V2P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of UBE2V2P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where UBE2V2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types UBE2V2P1 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

COAD, THCA, and READ are the cancer types where UBE2V2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2V2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Male	II,III,IV	+0.290	.008	2	view →
THCA	All	All	−0.058	.020	2	view →
READ	Female	All	+0.276	.043	1	view →
LUSC	Female	III,IV	−0.235	.004	1	view →
HNSC	Female	All	+0.061	.036	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: UBE2V2P1 RNA expression & survival · all UBE2V2P1 data types